Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Vaccine Contract Manufacturing Market Expected To Grow In Terms Of Size?
The market size of vaccine contract manufacturing has seen robust growth in the past few years. It is projected to expand from $3.58 billion in 2024 to $3.88 billion in 2025, witnessing a compound annual growth rate (CAGR) of 8.4%. The impressive growth in the historical phase can be linked to factors such as limitations in conventional vaccine manufacturing, the rise in global disease outbreaks, which has increased the demand for vaccines, regulatory backing for contract manufacturing, heightened complexity in vaccine production processes and a boom in vaccine research and development.
In the coming years, a rapid expansion is anticipated in the vaccine contract manufacturing market, with its size swelling to $5.78 billion in 2029 at a compound annual growth rate of 10.4%. The projected growth in this period can be linked to an increasing focus on readiness for pandemics, a rise in pharmaceutical manufacturing outsourcing, spread of biopharmaceutical companies, shortened vaccine development schedules, and worldwide initiatives promoting access to vaccines. Key trends expected during this forecast period comprise the incorporation of single-use technologies in manufacturing, a surge in bespoke approaches to vaccine creation, progress in mRNA and viral vector vaccines, adoption of uninterrupted manufacturing procedures, and extension of fill-finish services.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12216&type=smp
What Are The Primary Factors Supporting The Vaccine Contract Manufacturing Market Expansion?
The projected growth of the vaccine contract manufacturing market is attributed to escalating initiatives promoting vaccinations. Vaccination, an effective, safe, and simple method to prevent infectious diseases, strengthens the immune system and augments the body’s resistance to infections. An upsurge in such supportive programs is forecasted to enhance various vaccine manufacturing procedures, facilitating vaccine contract manufacturing. The U.S. Department of Health and Human Services, a cabinet-level executive branch in the US federal government, announced in November 2022 a fresh initiative – generously funded with $350 million – for HRSA-supported health facilities to increase the distribution of COVID-19 vaccines among their communities, primarily focusing on marginalized populations. Consequently, the growing focus on measures promoting vaccination is fueling the expansion of the vaccine contract manufacturing market.
Which Segmentation Categories Are Highlighted In The Vaccine Contract Manufacturing Market Analysis?
The vaccine contract manufacturingmarket covered in this report is segmented –
1) By Service Type: Fill-Finish; Bulk Product
2) By Vaccine Type: Inactivated Vaccines; Live-Attenuated Vaccines; RNA (Ribonucleic Acid) Vaccines; Subunit Vaccines; Toxoid-Based Vaccines
3) By Process: Downstream; Upstream
4) By Scale Of Operation: Preclinical; Clinical; Commercial
5) By End-Use: Human Use; Veterinary
Subsegments:
1) By Fill-Finish: Aseptic Fill-Finish; Lyophilization; Vial Filling; Syringe Filling
2) By Bulk Product: Cell Culture; Microbial Fermentation; Antigen Production; Buffer Preparation
Which Notable Trends Are Transforming The Vaccine Contract Manufacturing Market Outlook?
The notable uptick in strategic collaborations is a predominant trend to watch in the vaccine contract manufacturing sector. Leading corporations are joining forces with operating companies in this industry to uphold their market standing. For example, in January 2023, Vaxxas, a biotechnology company from Australia that specializes in innovative needle-free vaccination technology, entered a collaboration with the Coalition for Epidemic Preparedness Innovations – a foundation based in Norway. This partnership is intended to support and streamline the creation of new vaccines, focusing on promoting Vaxxas’ needle-free vaccine patch delivery technology – a revolutionary solution that might negate the need for frozen mRNA vaccine storage. Moreover, in October 2024, LenioBio, a biotech firm based in Germany, aligned with ReciBioPharm, an American Contract Development and Manufacturing Organization (CDMO) to bolster its protein production capacity and expedite vaccine manufacturing. This strategic alliance chimes with LenioBio’s plan to broaden its CEPI-funded project and demonstrate the promptness and efficacy of its unique ALiCE protein expression technology in the production of vaccine-associated proteins for clinical trials application.
Which Organizations Are At The Forefront Of The Vaccine Contract Manufacturing Market?
Major companies operating in the vaccine contract manufacturing market include Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Fujifilm Holdings Corporation, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Icon plc, Lonza Group AG, Cytiva, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Albany Molecular Research Inc., Soligenix Inc., Bio Farma, Curia Global Inc., Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., Biofabri S.L
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Vaccine Contract Manufacturing Market?
North America was the largest region in the vaccine contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in the vaccine contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12216&type=smp
Browse Through More Reports Similar to the Global Vaccine Contract Manufacturing Market 2025, By The Business Research Company
Orphan Drug Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report
Drug Delivery Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Autoimmune Disease Diagnosis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model